ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive, Metastatic Breast Cancer
Interventions: DRUG: ARX788
Sponsor: Fudan University